MT-ND1
NADH-ubiquinone oxidoreductase chain 1
Also known as: MTND1, NAD1, ND1, NU1M_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P03886
- Gene
- MT-ND1
- Ensembl
- ENSG00000198888
- Chromosome
- MT
- Canonical length
- 318 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins
OverviewNCBI Gene
Enables NADH dehydrogenase (ubiquinone) activity. Involved in mitochondrial electron transport, NADH to ubiquinone and mitochondrial respiratory chain complex I assembly. Located in mitochondrial inner membrane. Part of respiratory chain complex I. Implicated in several diseases, including MELAS syndrome; neurodegenerative disease (multiple); optic nerve disease (multiple); toxic shock syndrome; and type 2 diabetes mellitus. Biomarker of Alzheimer's disease; Parkinson's disease; and multiple sclerosis. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
318 residues, UniProt reviewed canonical sequence.
>P03886|MT-ND1
1 MPMANLLLLI VPILIAMAFL MLTERKILGY MQLRKGPNVV GPYGLLQPFA DAMKLFTKEP
61 LKPATSTITL YITAPTLALT IALLLWTPLP MPNPLVNLNL GLLFILATSS LAVYSILWSG
121 WASNSNYALI GALRAVAQTI SYEVTLAIIL LSTLLMSGSF NLSTLITTQE HLWLLLPSWP
181 LAMMWFISTL AETNRTPFDL AEGESELVSG FNIEYAAGPF ALFFMAEYTN IIMMNTLTTT
241 IFLGTTYDAL SPELYTTYFV TKTLLLTSLF LWIRTAYPRF RYDQLMHLLW KNFLPLTLAL
301 LMWYVSMPIT ISSIPPQTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MT-ND1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 8
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 129,323 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 129,323 nTPM
- basal ganglia: 79,754 nTPM
- hippocampal formation: 65,750 nTPM
- skeletal muscle: 64,874 nTPM
- amygdala: 64,829 nTPM
- midbrain: 59,022 nTPM
Single-cell type
- colonocytes: 18,500 nCPM
- enterocytes: 16,662 nCPM
- hepatocytes: 14,993 nCPM
- goblet cells: 14,766 nCPM
- enteric stem cells: 12,581 nCPM
- enteric transient amplifying cells: 12,429 nCPM
Immune cell
- basophil: 9,528 nTPM
- neutrophil: 3,286 nTPM
- eosinophil: 2,358 nTPM
- classical monocyte: 1,271 nTPM
- naive B-cell: 1,191 nTPM
- memory B-cell: 1,161 nTPM
Brain region
- cerebral cortex: 81,514 nTPM
- pons: 61,336 nTPM
- midbrain: 55,199 nTPM
- medulla oblongata: 53,802 nTPM
- thalamus: 49,029 nTPM
- choroid plexus: 48,569 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MT-ND1.
Disease | AllUniProt
Conditions MT-ND1 is implicated in, by any mechanism.
- Leber hereditary optic neuropathy (LHON) MIM:535000
- Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome (MELAS) MIM:540000
- Alzheimer disease mitochondrial (AD-MT) MIM:502500
- Type 2 diabetes mellitus (T2D) MIM:125853
Disease | GeneticClinVar
11 pathogenic / likely-pathogenic of 189 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Mitochondrial disease
- Primary Mitochondrial Disorders
- Leber optic atrophy
- Leber optic atrophy and dystonia
- Leigh syndrome
OntologyGO
Biological processes
- aerobic respiration
- mitochondrial electron transport, NADH to ubiquinone
- mitochondrial respiratory chain complex I assembly
- proton motive force-driven mitochondrial ATP synthesis
- response to hydroperoxide
- response to hypoxia
- response to xenobiotic stimulus
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- NADH:ubiquinone oxidoreductase, subunit 1/F420H2 oxidoreductase subunit H
- NADH:ubiquinone oxidoreductase, subunit 1, conserved site
- NADH dehydrogenase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MT-ND1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MT-ND1 as an antibody target. Whether an autoantibody or antibody against MT-ND1 could matter depends on whether native MT-ND1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MT-ND1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MT-ND1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...